Cipher Pharmaceuticals Inc.

TSX:CPH 주식 보고서

시가총액: CA$374.9m

Cipher Pharmaceuticals 관리

관리 기준 확인 2/4

Cipher Pharmaceuticals CEO는 Craig Mull, Jul2019 에 임명되었습니다 의 임기는 5.33 년입니다. 는 CA$ 11.97M 가치에 해당하는 회사 주식의 3.19% 직접 소유합니다. 11.97M. 경영진과 이사회의 평균 재임 기간은 각각 2.5 년과 3.5 년입니다.

주요 정보

Craig Mull

최고 경영자

US$1.0m

총 보상

CEO 급여 비율n/a
CEO 임기5.3yrs
CEO 소유권3.2%
경영진 평균 재임 기간2.5yrs
이사회 평균 재임 기간3.5yrs

최근 관리 업데이트

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

CEO

Craig Mull

5.3yrs

테뉴어

US$1,045,700

보상

Mr. Craig J. Mull has been Chairman of the Board of Directors at Cipher Pharmaceuticals Inc. since June 11, 2019 and its Interim Chief Executive Officer since July 29, 2019, served as its President. Mr. Mu...

리더십 팀

이름위치테뉴어보상소유권
Craig Mull
Interim CEO & Chairman of the Board5.3yrsUS$1.05m3.19%
CA$ 12.0m
Bryan Jacobs
Chief Financial Officer2.3yrsUS$391.35k0.020%
CA$ 73.3k
Emilio Presti
Director of Sales & Marketing2.8yrs데이터 없음데이터 없음
Hamed Ghanei
Chief Business Officerless than a year데이터 없음데이터 없음

2.5yrs

평균 재임 기간

경험이 풍부한 관리: CPH 의 관리팀은 경험 ( 2.5 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Craig Mull
Interim CEO & Chairman of the Board5.7yrsUS$1.05m3.19%
CA$ 12.0m
Harold Wolkin
Lead Independent Director8.3yrsUS$73.49k1.43%
CA$ 5.4m
Douglas Deeth
Independent Director1.4yrsUS$65.57k데이터 없음
Hubert Walinski
Independent Director1.4yrsUS$62.57k데이터 없음

3.5yrs

평균 재임 기간

경험이 풍부한 이사회: CPH 의 이사회는 경험(평균 재직 기간 3.5 년)으로 간주됩니다.